Most recently reported pay: $4.4M. No year-by-year proxy breakdown is on file — common for foreign private issuers and recently listed companies, which do not file a US proxy statement.
Names, titles and pay as reported by the company and its SEC filings, via Financial Modeling Prep. Reference only — nothing here is investment advice, and no affiliation with or endorsement by the people listed is implied.
Abbott declares 411th consecutive quarterly dividend
Sep 17, 2026https://www.prnewswire.com/news-releases/abbott-declares-411th-consecutive-quarterly-dividend-302882411.htmlsentiment +0.60
Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott
Sep 13, 2026https://247wallst.com/investing/2026/09/13/two-medical-device-dividend-giants-one-better-buy-medtronic-vs-abbott/sentiment +0.30
SCHD's Stunning Reversal: Schwab's Flagship Dividend ETF Is Up 29% and Climbing
Sep 13, 2026https://www.fool.com/investing/2026/09/13/schds-stunning-reversal-schwabs-flagship-dividend/sentiment -0.20
Benjamin Edwards Inc. Has $20.96 Million Stake in Abbott Laboratories $ABT
Sep 5, 2026https://www.defenseworld.net/2026/09/05/benjamin-edwards-inc-has-20-96-million-stake-in-abbott-laboratories-abt.htmlsentiment +0.60
The Free Retirement Dinner Costs $500K in the Fine Print, but These 4 ETFs Do What the Steak Pitch Promises
Aug 31, 2026https://247wallst.com/investing/etf/2026/08/31/the-free-retirement-dinner-costs-500k-in-the-fine-print-but-these-4-etfs-do-what-the-steak-pitch-promises/sentiment +0.00
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
Aug 25, 2026https://www.prnewswire.com/news-releases/abbott-receives-fda-authorization-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes-302859742.htmlsentiment +1.00
